Lifecore Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Lifecore Biomedical
LFCR Stock   6.57  0.02  0.31%   
Lifecore Biomedical financial statements provide useful quarterly and yearly information to potential Lifecore Biomedical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Lifecore Biomedical financial statements helps investors assess Lifecore Biomedical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Lifecore Biomedical's valuation are summarized below:
Gross Profit
45.6 M
Profit Margin
(0.11)
Market Capitalization
242.5 M
Enterprise Value Revenue
2.7621
Revenue
130.9 M
There are over ninety available fundamental ratios for Lifecore Biomedical, which can be analyzed over time and compared to other ratios. Investors and active traders are advised to check Lifecore Biomedical's last-minute fundamental performance against the performance between 2010 and 2025 to make sure the trends are evolving in the right direction. As of 03/19/2025, Market Cap is likely to drop to about 42.4 M. In addition to that, Enterprise Value is likely to drop to about 37.1 M

Lifecore Biomedical Total Revenue

140.13 Million

Check Lifecore Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lifecore Biomedical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.4 M, Interest Expense of 21.8 M or Total Revenue of 140.1 M, as well as many indicators such as Price To Sales Ratio of 0.2, Dividend Yield of 0.0 or PTB Ratio of 0.74. Lifecore financial statements analysis is a perfect complement when working with Lifecore Biomedical Valuation or Volatility modules.
  
Check out the analysis of Lifecore Biomedical Correlation against competitors.
To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.

Lifecore Biomedical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets248.7 M314.8 M335.3 M
Pretty Stable
Short and Long Term Debt Total157.4 M149.9 M106.8 M
Slightly volatile
Other Current Liabilities14.2 M17.8 M17.7 M
Slightly volatile
Total Current Liabilities55 M44.7 M70 M
Pretty Stable
Total Stockholder Equity58.9 M62 M160.7 M
Slightly volatile
Property Plant And Equipment Net182.4 M173.7 M131.6 M
Slightly volatile
Accounts Payable22.1 M18.8 M26.4 M
Very volatile
Cash10.6 M7.6 M8.1 M
Slightly volatile
Non Current Assets Total161.8 M198.9 M232.6 M
Pretty Stable
Cash And Short Term Investments13.1 M7.6 M8.3 M
Slightly volatile
Common Stock Shares Outstanding26.4 M42.2 M28.1 M
Slightly volatile
Liabilities And Stockholders Equity248.7 M314.8 M335.3 M
Pretty Stable
Non Current Liabilities Total218.5 M208.1 M109.1 M
Slightly volatile
Inventory26.6 M46 M38.5 M
Slightly volatile
Other Current Assets1.6 M1.7 M10.7 M
Pretty Stable
Other Stockholder Equity121.9 M204.5 M145.5 M
Slightly volatile
Total Liabilities265.4 M252.8 M178.7 M
Slightly volatile
Total Current Assets86.2 M93.2 M100 M
Slightly volatile
Short Term Debt5.4 M5.6 M30.3 M
Slightly volatile
Net Receivables33.9 M35.8 M43.2 M
Pretty Stable
Intangible Assets4.6 M4.8 M29.7 M
Slightly volatile
Common Stock25.6 K27 K4.9 M
Slightly volatile
Current Deferred Revenue1.3 M1.9 M1.2 M
Very volatile
Short Term Investments1.7 M1.8 M1.6 M
Very volatile
Good Will15.2 M16 M42.2 M
Slightly volatile
Other Liabilities3 M3.1 M14.1 M
Slightly volatile
Other Assets25.1 M17.8 M15.6 M
Pretty Stable
Long Term Debt123.4 M138.6 M102 M
Slightly volatile
Capital Lease Obligations12.9 M8.2 M9.1 M
Slightly volatile
Net Invested Capital228.8 M119.3 M338.6 M
Slightly volatile
Long Term Investments43.5 M40.6 M54.5 M
Slightly volatile
Short and Long Term Debt660.9 K695.7 K44.8 M
Slightly volatile
Capital Stock32.5 K34.5 K29.7 K
Slightly volatile
Non Current Liabilities Other3.4 M5.8 M2.6 M
Slightly volatile
Property Plant Equipment132.6 M121.1 M176.1 M
Slightly volatile
Property Plant And Equipment Gross142.9 M181.2 M198.5 M
Slightly volatile

Lifecore Biomedical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense21.8 M20.8 M8.7 M
Slightly volatile
Total Revenue140.1 M147.5 M365.9 M
Slightly volatile
Gross Profit50.2 M48.1 M59.7 M
Very volatile
Other Operating Expenses308.9 M155.8 M370.2 M
Pretty Stable
Research Development7.4 M9.9 M8.8 M
Pretty Stable
Cost Of Revenue94.4 M99.4 M306.5 M
Slightly volatile
Total Operating Expenses42.6 M56.4 M52.9 M
Slightly volatile
Selling General Administrative57.3 M49.5 M48.7 M
Slightly volatile
Selling And Marketing Expenses4.4 K4.6 K700.1 K
Slightly volatile
Interest Income71.2 K61.2 K112.8 K
Slightly volatile
Reconciled Depreciation12.6 M8 M14.8 M
Slightly volatile

Lifecore Biomedical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow11.1 M17.2 M9.2 M
Very volatile
Depreciation8.2 M10.2 M11.1 M
Slightly volatile
Capital Expenditures16.4 M20.6 M21.9 M
Slightly volatile
End Period Cash Flow10.9 M7.6 M8.1 M
Slightly volatile
Dividends Paid2.6 M2.8 M6.5 M
Slightly volatile
Change To Netincome31.8 M37 M16.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.20.21431.1943
Slightly volatile
PTB Ratio0.740.70142.8702
Slightly volatile
Days Sales Outstanding33.8546.704482.6069
Slightly volatile
Book Value Per Share3.963.16661.9931
Slightly volatile
Average Payables26.7 M39.1 M19.3 M
Slightly volatile
Stock Based Compensation To Revenue0.00.00.0423
Slightly volatile
Capex To Depreciation0.690.72741.8586
Slightly volatile
PB Ratio0.740.70142.8702
Slightly volatile
EV To Sales0.250.26722.0323
Slightly volatile
Inventory Turnover14.0411.15483.4659
Slightly volatile
Days Of Inventory On Hand46.324.3333152
Slightly volatile
Payables Turnover9.7313.18756.0613
Slightly volatile
Sales General And Administrative To Revenue0.120.110.3603
Slightly volatile
Research And Ddevelopement To Revenue0.0190.020.0609
Slightly volatile
Capex To Revenue0.01320.01390.124
Slightly volatile
Cash Per Share0.810.43190.3206
Slightly volatile
Days Payables Outstanding27.7627.677663.8353
Slightly volatile
Intangibles To Total Assets0.30.34770.0983
Slightly volatile
Net Debt To EBITDA2.542.03743.2818
Slightly volatile
Current Ratio1.021.07561.955
Slightly volatile
Tangible Book Value Per Share2.181.10411.2338
Slightly volatile
Receivables Turnover10.997.81514.7778
Slightly volatile
Graham Number5.714.00474.0729
Slightly volatile
Shareholders Equity Per Share3.923.07961.9852
Slightly volatile
Debt To Equity0.330.31352.1564
Slightly volatile
Capex Per Share0.130.14010.5314
Slightly volatile
Average Receivables20.2 M33.4 M34 M
Pretty Stable
Revenue Per Share8.9510.0794.8721
Slightly volatile
Interest Debt Per Share1.770.96544.4334
Slightly volatile
Debt To Assets0.150.16270.4363
Slightly volatile
Enterprise Value Over EBITDA9.1810.2878.4214
Slightly volatile
Operating Cycle80.1471.0377235
Slightly volatile
Price Book Value Ratio0.740.70142.8702
Slightly volatile
Days Of Payables Outstanding27.7627.677663.8353
Slightly volatile
Pretax Profit Margin0.00120.00110.065
Slightly volatile
Ebt Per Ebit0.150.15980.9115
Slightly volatile
Operating Profit Margin0.00720.00690.0645
Slightly volatile
Effective Tax Rate14.3413.65671.7666
Slightly volatile
Company Equity Multiplier2.021.92634.6897
Slightly volatile
Long Term Debt To Capitalization0.08150.08580.615
Slightly volatile
Total Debt To Capitalization0.220.23870.6477
Slightly volatile
Return On Capital Employed0.01220.01950.0367
Slightly volatile
Debt Equity Ratio0.330.31352.1564
Slightly volatile
Ebit Per Revenue0.00720.00690.0645
Slightly volatile
Quick Ratio0.80.84141.0267
Slightly volatile
Cash Ratio0.170.18160.2125
Slightly volatile
Cash Conversion Cycle52.3843.3601171
Slightly volatile
Days Of Inventory Outstanding46.324.3333152
Slightly volatile
Days Of Sales Outstanding33.8546.704482.6069
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio27.5226.207976.4951
Slightly volatile
Price To Book Ratio0.740.70142.8702
Slightly volatile
Fixed Asset Turnover6.49.20281.7182
Slightly volatile
Enterprise Value Multiple9.1810.2878.4214
Slightly volatile
Debt Ratio0.150.16270.4363
Slightly volatile
Price Sales Ratio0.20.21431.1943
Slightly volatile
Asset Turnover1.361.6990.6012
Slightly volatile
Gross Profit Margin0.240.17110.3112
Slightly volatile
Price Fair Value0.740.70142.8702
Slightly volatile

Lifecore Biomedical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap42.4 M44.7 M121.3 M
Slightly volatile
Enterprise Value37.1 M39 M126 M
Slightly volatile

Lifecore Fundamental Market Drivers

Forward Price Earnings8.673
Cash And Short Term Investments8.5 M

Lifecore Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
6th of June 2024
Next Financial Report
View
30th of November 2023
Next Fiscal Quarter End
View
29th of August 2024
Next Fiscal Year End
View
31st of August 2023
Last Quarter Report
View
31st of May 2023
Last Financial Announcement
View

About Lifecore Biomedical Financial Statements

Lifecore Biomedical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Lifecore Biomedical investors may analyze each financial statement separately, they are all interrelated. The changes in Lifecore Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Lifecore Biomedical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.9 M1.3 M
Total Revenue147.5 M140.1 M
Cost Of Revenue99.4 M94.4 M
Sales General And Administrative To Revenue 0.11  0.12 
Research And Ddevelopement To Revenue 0.02  0.02 
Capex To Revenue 0.01  0.01 
Revenue Per Share 10.08  8.95 
Ebit Per Revenue 0.01  0.01 

Additional Tools for Lifecore Stock Analysis

When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY